Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions

AIDS Research and Human Retroviruses

Volumn 14, Issue 2, 1998, Pages 151-155

  Lu, S ^a   Wyatt, R ^a   Richmond, J F L ^a   Mustafa, F ^a   Wang, S ^a   Weng, J ^a   Montefiori, D C ^a   Sodroski, J ^a   Robinson, H L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 140; GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; DNA TRANSFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT;

EID: 0031906852     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.151     Document Type: Article

References (18)